Company Performance Metrics
CELYSTRA Pharma is a biopharmaceutical company that identifies and acquires innovative therapies developed internationally and brings them to Canada. The company focuses on making treatments available to patients with rare and specialized diseases who face unmet medical needs. CELYSTRA Pharma licenses and commercializes therapies, working to
facilitate access to medicines that address gaps in current treatment options. It collaborates with international partners to introduce these products into the Canadian healthcare system. The company begins its activities with a Health Canada–approved treatment for familial chylomicronemia syndrome, a rare genetic disorder. CELYSTRA Pharma concentrates on underserved patient populations and structured market access for novel therapies.
